Completion of therapy for latent tuberculosis in children of different nationalities

Pediatric Infectious Disease Journal

Volumn 27, Issue 3, 2008, Pages 272-274

  Powell, Dwight A ^a,b   Perkins, Lori ^a   Wang, Shu Hua ^a,c   Hunt, Garrett ^a,b   Ryan Wenger, Nancy ^a  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Completion of therapy; Different nationalities; Latent tuberculosis

Indexed keywords

BCG VACCINE; ISONIAZID; TUBERCULOSTATIC AGENT;

ADOLESCENT; AFRICA; ANTIBIOTIC THERAPY; ARTICLE; CENTRAL AMERICA; CHILD; CLINICAL PRACTICE; DRUG WITHDRAWAL; EASTERN EUROPE; HUMAN; LATENT PERIOD; LATENT TUBERCULOSIS INFECTION; MAJOR CLINICAL STUDY; MIDDLE EAST; MYCOBACTERIUM TUBERCULOSIS; PARENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; SOUTH AMERICA; THORAX RADIOGRAPHY; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT REFUSAL; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES; AFRICA SOUTH OF THE SAHARA; ASIA; COMPARATIVE STUDY; ETHNIC GROUP; INFANT; PARENTAL CONSENT; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ADOLESCENT; AFRICA SOUTH OF THE SAHARA; ANTITUBERCULAR AGENTS; ASIA; CENTRAL AMERICA; CHILD; CHILD, PRESCHOOL; ETHNIC GROUPS; EUROPE, EASTERN; HUMANS; INFANT; PARENTAL CONSENT; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; SOUTH AMERICA; TUBERCULOSIS; UNITED STATES;

EID: 44949189682     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181609a0a     Document Type: Article

References (10)

1. Bjune G, Cotton M, El Sony A, et al. Guidance for national tuberculosis programmes on the management of tuberculosis in children. World Health Organization Publication WHO/HTTM/TB/2006.371; 2006. Available at: http://www.who.int/child-adolescent-health/New-Publications/CHILD-HEALTH/ WHO-FCH-CAH-2006.7.pdf. Accessed October 10, 2007.
2. Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med. 2004;350:2060-2067.
3. American Thoracic Society, Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161:S221-S247.
4. Pediatric Tuberculosis Collaborative Group. Targeted tuberculin testing and treatment of latent tuberculosis infection in children and adolescents. Pediatrics. 2004;114:1175-1201.
5. Shieh FK, Snyder G, Horsburgh CR, et al. Predicting non-completion of treatment for latent tuberculous infection: a prospective survey. Am J Respir Crit Care Med. 2006;174:717-721.
6. Yuan L, Richardson E, Kendall PR. Evaluation of a tuberculosis screening program for high-risk students in Toronto schools. CMAJ. 1995;153: 925-932.
7. LoBue PA, Moser KS. Use of isoniazid for latent tuberculosis infection in a public health clinic. Am J Respir Crit Care Med. 2003;168:443-447.
8. Brassard P, Steensma C, Cadieux L, Lands LC. Evaluation of a school- based tuberculosis-screening program and associate investigation targeting recently immigrated children in a low-burden country. Pediatrics. 2006;117:e148-e156.
9. Varkey P, Jerath AU, Bagniewski SM, Lesnick TG. The epidemiology of tuberculosis among primary refugee arrivals in Minnesota between 1997 and 2001. J Travel Med. 2007;14:1-8.0
10. Spyridis NP, Spyridis PG, Gelesme A, et al. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study. Clin Infect Dis. 2007;45:715-722.